• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Awareness of diabetes mellitus among diabetic patients in the Gambia: a strong case for health education and promotion
Conclusion: Our study shows that the majority of patients attending the MOPD have poor knowledge on several aspects of DM. Hence, there is need for conscious efforts towards improving the level of awareness through health education and promotion, not limited to the hospital but also within the general population, as part of strategies to prevent, manage and control DM.
Source: BMC Public Health - Latest articles - December 5, 2013 Category: Consumer Health News Authors: Mafomekong FomaYauba SaiduSameeh OmolekeJames Jafali Source Type: research

Study may bust myth of 'fat and fit' healthy obesity
Conclusion This meta-analysis provides further evidence about the known risk factors for cardiovascular disease and mortality. What this study adds is the indication that people who are metabolically unhealthy regardless of their weight are at increased risk. However, interestingly, no increase in risk was seen for the category of people who are metabolically healthy though overweight. A strength of this meta-analysis is the large sample size. However, the results should be interpreted with caution as: The studies did not use the same criteria for assessing metabolic status. The studies did not use the same criteri...
Source: NHS News Feed - December 4, 2013 Category: Consumer Health News Tags: Food/diet Lifestyle/exercise Obesity Source Type: news

Tighter transfusion strategy recommended to treat anemia in patients with heart disease
Red blood cell (RBC) transfusions should be restricted to those individuals with severe anemia in patients with heart disease, the American College of Physicians (ACP) recommends in a new clinical practice guideline published in Annals of Internal Medicine, ACP's flagship journal.ACP also recommends against using erythropoiesis-stimulating agents (ESAs) in patients with mild to moderate anemia and congestive heart failure (CHF) or coronary artery disease (CHD) because the harms, including increased risks of thromboembolic events and stroke rates, outweigh the benefits.
Source: Health News from Medical News Today - December 3, 2013 Category: Consumer Health News Tags: Blood / Hematology Source Type: news

High salt levels in soluble drugs may raise heart risk
Conclusion This large case control study suggested that people who had experienced disease of the heart and blood vessels were more likely to have taken sodium-containing medicines than people without cardiovascular disease. Put in other words this can be interpreted that people who took sodium-containing medicines were at a higher risk of experiencing cardiovascular disease than people who took the same medications in formulations free of sodium. The increased risk appeared to be driven mostly by an increased risk of hypertension and to a lesser extent, non-fatal stroke. The study has some strengths including its large s...
Source: NHS News Feed - November 27, 2013 Category: Consumer Health News Tags: Heart/lungs Medication Medical practice Source Type: news

ACE inhibitor use may be linked to kidney failure
Conclusion ACE inhibitors and ARAs are recognised as a potential risk factor for AKI in some patients. This particular study has tried to estimate the possible size of the problem, but its findings should be viewed with some caution. As the authors point out: some of the conditions these drugs are prescribed for are themselves a risk factor for AKI changes in hospital coding and better recognition of AKI could explain the rise in admissions an ageing population leads to both increased prescribing of these drugs and an increased risk for AKI increased use of these drugs may be a marker for increased use of other...
Source: NHS News Feed - November 7, 2013 Category: Consumer Health News Tags: Medication Heart/lungs Source Type: news

Can DIY and gardening help you live longer?
Conclusion This study found that in a population-based sample of older adults (aged 60), high levels of non-exercise physical activity, or ‘an active daily life’ was associated with better levels of cardiovascular risk factors. When followed over time, it was found an active daily life was associated with approximately 30% reduced risk of both a cardiovascular event (stroke, angina, heart attack) and death from any cause. These associations were seen after adjusting for regular exercise, and for a number of other factors that could explain the association seen (confounders). This study was a cross-sectional and cohort...
Source: NHS News Feed - October 29, 2013 Category: Consumer Health News Tags: Lifestyle/exercise Heart/lungs Source Type: news

Could exercise be as effective as medication?
Conclusion The researchers found that there are very few trials that directly compare exercise with drug therapy for any condition. They were only able to find enough trials to be able to analyse results for four major conditions. They found that exercise reduced death rates for people after a stroke (although this analysis has limitations and should be interpreted cautiously), and that drug therapy with diuretics improved death rates for people with heart failure. They did not find any difference between exercise and drug therapy for death rates after a heart attack or in people with pre-diabetes. There were several limit...
Source: NHS News Feed - October 2, 2013 Category: Consumer Health News Tags: Lifestyle/exercise Heart/lungs Medication Source Type: news

Guideline: ACP recommends weight loss and CPAP therapy for obstructive sleep apnea
People diagnosed with obstructive sleep apnea (OSA) should not consider surgery, according to new recommendations from the American College of Physicians (ACP). Instead, ACP recommends that patients lose weight and use continuous positive airway pressure (CPAP) as initial therapy. More than 18 million American adults have sleep apnea, which increases the risk of high blood pressure, heart attack, stroke, heart failure, and diabetes and increases the chance of driving or other accidents. Sleep apnea is a leading cause of excessive daytime sleepiness...
Source: Health News from Medical News Today - September 25, 2013 Category: Consumer Health News Tags: Sleep / Sleep Disorders / Insomnia Source Type: news

American College of Physicians releases new recommendations for treating obstructive sleep apnea
People diagnosed with obstructive sleep apnea (OSA) should lose weight and use continuous positive airway pressure (CPAP) as initial therapy, according to new recommendations from the American College of Physicians (ACP) published today in Annals of Internal Medicine, ACP's flagship journal. More than 18 million American adults have sleep apnea, which increases the risk of high blood pressure, heart attack, stroke, heart failure, and diabetes and increases the chance of driving or other accidents. Sleep apnea is a leading cause of excessive daytime sleepiness...
Source: Health News from Medical News Today - September 24, 2013 Category: Consumer Health News Tags: Sleep / Sleep Disorders / Insomnia Source Type: news

Saxagliptin, Alogliptin No Help or Harm CV Risk in DiabeticsSaxagliptin, Alogliptin No Help or Harm CV Risk in Diabetics
However, there was an increased risk of hospitalizations for heart failure among patients treated with saxagliptin. On the whole, however, cardiologists feel the results are helpful for colleagues treating diabetic patients, as they rule out a risk of MI, stroke, or cardiovascular mortality. Heartwire
Source: Medscape Today Headlines - September 2, 2013 Category: Consumer Health News Tags: Cardiology News Source Type: news

Five genes identified that play major role in Takayasu arteritis
Researchers have uncovered the genetics behind what makes some people susceptible to Takayasu arteritis, a debilitating disease that can lead to poor circulation, easy tiredness in the legs and arms, organ damage and stroke. A study led by the University of Michigan has identified five genes tied to Takayasu arteritis, an inflammation that damages the aorta and can lead to narrowed arteries, aneurysms, high blood pressure, and heart failure. The findings appear in the August issue of The American Journal of Human Genetics...
Source: Health News from Medical News Today - July 31, 2013 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news

Diabetics Taking Certain Blood Pressure Drugs At Lower Risk Of Heart Disease
Two drugs, telmisartan and valsartan, which are used to reduce blood pressure in people with diabetes, are associated with a lower risk of hospitalization for heart attack, stroke or heart failure, according to a study published in CMAJ (Canadian Medical Association Journal). For people with type 2 diabetes, disease-related vascular illnesses are the main causes of death. Angiotensin-receptor blockers including telmisartan, valsartan, candesartan, irbesartan and losartan, are generally used interchangeably to control blood pressure...
Source: Health News from Medical News Today - July 10, 2013 Category: Consumer Health News Tags: Hypertension Source Type: news

Two ARBs Lower Risk of CVD Complications in DiabeticsTwo ARBs Lower Risk of CVD Complications in Diabetics
Compared with irbesartan, the use of telmisartan and valsartan lowered the risk of hospital admission for MI, stroke, or heart failure by 15% and 14%, respectively. The reduction was driven primarily by a reduction in the risk of heart-failure hospitalizations. Heartwire
Source: Medscape Today Headlines - July 8, 2013 Category: Consumer Health News Tags: Cardiology News Source Type: news

Common Painkiller Linked To Heart Attack And Stroke, UK Warning
Common painkiller, diclofenac, raises the risk of heart attack and stroke among patients with serious underlying heart conditions, the UK's Medicines and Healthcare Products Regulatory Agency (MHRA) has warned. MHRA specifies that patients with circulatory problems, heart disease, heart failure, or a previous stroke or heart attack should stop using diclofenac. Diclofenac is known under several trade names, including Diclomax, Defenac, Diclofex, Dyloject, Econac, Enstar, Flamrase, Flamatak, Motifene, Rheumatac, Rhumalgan, Volsaid, and Voltarol...
Source: Health News from Medical News Today - July 1, 2013 Category: Consumer Health News Tags: Pain / Anesthetics Source Type: news

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13